CUCCURULLO, Chiara
Dettaglio
CUCCURULLO, Chiara
DIPARTIMENTO DI MEDICINA E DI SCIENZE DELLA SALUTE
Pubblicazioni
Risultati 1 - 20 di 40 (tempo di esecuzione: 0.0 secondi).
Titolo | Data di pubblicazione | Autore(i) | |
---|---|---|---|
1 | 4 Ascorbic acid supplementation reduces oxidative stress and platelet biochemical function in type 2 diabetic patients. Relevance of ascorbic acid dosage and formulation. | 2011 | Lapenna D; Ciofani G; Cuccurullo C; Pierdomenico SD; Cuccurullo F. |
2 | A Polymorphism in the Cyclooxygenase 2 Gene as an Inherited Protective Factor Against Myocardial Infarction and Stroke | 2004 | Cipollone F.; Toniato E.; Martinotti S.; Fazia M.; Iezzi A.; Cuccurullo C.; Pini B.; Ursi S.; Vitullo G.; Averna M.; Arca M.; Montali A.; Campagna F.; Ucchino S.; Spigonardo F.; Taddei S.; Virdis A.; Ciabattoni G.; Notarbartolo A.; Cuccurullo F.; Mezzetti A. |
3 | Association between 5-lipoxygenase expression and plaque instability in humans. | 2005 | Cipollone F; Mezzetti A; Fazia ML; Cuccurullo C; Iezzi A; Ucchino S; Spigonardo F; Bucci M; Cuccurullo F; Prescott SM; Stafforini DM |
4 | Association between prostaglandin E receptor subtype EP4 overexpression and unstable phenotype in atherosclerotic plaques in human. | 2005 | CIPOLLONE F; FAZIA ML; IEZZI A; CUCCURULLO C; DE CESARE D; UCCHINO S; SPIGONARDO F; MARCHETTI A; F. BUTTITTA; PALOSCIA L; MASCELLANTI M; CUCCURULLO F; MEZZETTI A |
5 | Autism and Immunity: Revisited Study | 2009 | CASTELLANI M.L; CONTI C.M; KEMPURAJ D.J; SALINI V; VECCHIET J; TETÈ S; CIAMPOLI C; CONTI F; CERULLI G; CARAFFA A; ANTINOLFI P; GALLIO R; SHAIK Y; THEOHARIDES T.C; DE AMICIS D; PERRELLA A; CUCCURULLO C; BOSCOLO P; FELACO M; DOYLE R; M. VERROCCHIO; FULCHERI M |
6 | Bicarbonate-dependent, carbonate radical anion-driven tocopherol-mediated human LDL peroxidation: An in vitro and in vivo study | 2012 | Lapenna D; Ciofani G; Cuccurullo C; Neri M; Giamberardino MA; Cuccurullo F. |
7 | Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteases activity | 2004 | Cipollone F; Fazia M; Iezzi A; Pini B; Cuccurullo C; Zucchelli M; de Cesare D; Ucchino S; Spigonardo F; De Luca M; Muraro R; Bei R; Bucci M; Cuccurullo F; Mezzetti A. |
8 | Cardiac Events in Hypertensive Patients With Renal Artery Stenosis Treated With Renal Angioplasty or Drug Therapy: Meta-Analysis of Randomized Trials | 2012 | Pierdomenico SD; Pierdomenico AM; Cuccurullo C; Mancini M; Di Carlo S; Cuccurullo F. |
9 | Cardiovascular risk and dietary sugar intake: Is the link so sweet? | 2012 | Mucci L; Santilli F; Cuccurullo C; Davì G |
10 | COX-2 and the vasculature: angel or evil? | 2007 | CUCCURULLO C; A. MEZZETTI; CIPOLLONE F |
11 | COX-2 expression in atherosclerosis: the good, the bad or the ugly? | 2007 | CUCCURULLO C; FAZIA ML; MEZZETTI A; CIPOLLONE F |
12 | Determinants of increased cardiovascular disease in obesity and metabolic syndrome. | 2011 | Vazzana N; Santilli F; Sestili S; Cuccurullo C; Davi G. |
13 | Determinants of platelet activation in hypertensives with microalbuminuria. | 2009 | GUAGNANO M.T; FERRONI P; SANTILLI F; PAOLETTI V; MANIGRASSO M.R; PESCARA L; CUCCURULLO C; G. CIABATTONI; DAVI' G |
14 | Diabetes mellitus and thrombosis.. | 2012 | Vazzana N; Ranalli P; Cuccurullo C; Davì G. |
15 | Endogenous secretory RAGE in obese women: Association with platelet activation and oxidative stress | 2012 | Vazzana N; Guagnano MT; Cuccurullo C; Ferrante E; Lattanzio S; Liani R; Romano M; Davì G |
16 | Enhanced soluble CD40 ligand contributes to endothelial cell dysfunction in vitro and monocyte activation in patients with diabetes mellitus: effect of improved metabolic control | 2005 | CIPOLLONE F; CHIARELLI F; DAVI' G; FERRI C; DESIDERI G; FAZIA M; IEZZI A; F. SANTILLI; PINI B; CUCCURULLO C; TUMINI S; DEL PONTE A; CANTUCCI A; CUCCURULLO F; MEZZETTI A |
17 | IL-32: a newly-discovered proinflammatory cytokine | 2009 | Felaco P; Castellani ML; De Lutiis MA; Felaco M; Pandolfi F; Salini V; De Amicis D; Vecchiet J; Tete S; Ciampoli C; Conti F; Cerulli G; Caraffa A; Antinolfi P; Cuccurullo C; Perrella A; Theoharides TC; Conti P; Toniato E; Kempuraj D; Shaik YB |
18 | IL-35, an anti-inflammatory cytokine which expands CD4+CD25+ Treg Cells. | 2010 | Castellani ML; Anogeianaki A; Felaco P; Toniato E; De Lutiis MA; Shaik B; Fulcheri M; Vecchiet J; Tetè S; Salini V; Theoharides TC; Caraffa A; Antinolfi P; Frydas I; Conti P; Cuccurullo C; Ciampoli C; Cerulli G; Kempuraj D. |
19 | Impact of IL-32 on histamine release by human derived umbilical cord blood mast cells | 2009 | Castellani M.L.; Toniato E.; Felaco P.; Ciampoli C.; De Amicis D.; Orso C.; Cuccurullo C.; Vecchiet J.; Tetè S.; Salini V.; Caraffa A.; Pandolfi F.; Antinolfi P.L.; Cerulli G.; Conti F.; Fulcheri M.; Sabatino G.; Boscolo P.; Conti P.; Shaik Y.B. |
20 | Impact of RANTES, MCP-1 and IL-8 in mast cells | 2010 | Castellani M.L.; De Lutiis M.A.; Toniato E.; Conti F.; Felaco P.; Fulcheri M.; Theoharides T.C.; Caraffa A.; Antinolfi P.; Conti P.; Cuccurullo C.; Ciampoli C.; Felaco M.; Orso C.; Salini V.; Cerulli G.; Kempuraj D.; Tetè S.; Shaik B. |